NCT03802539 is a NA clinical trial of Glass Liner in Teeth; Lesion, sponsored by Hacettepe University.

Who is sponsoring NCT03802539?

NCT03802539 is sponsored by Hacettepe University.

What drugs are being tested in NCT03802539?

Interventions in NCT03802539: Glass Liner.

What condition does NCT03802539 study?

NCT03802539 studies Teeth; Lesion, Dental Root Caries.

Is NCT03802539 still recruiting?

NCT03802539 is currently status unknown. Last updated 14 January 2019.

Last reviewed 2019-01-14 · How we verify

NCT03802539

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

5-year Clinical Evaluation of Cavity Lining on the Restoration

Status unknown NA Last updated 14 January 2019

What this trial tests

NA trial testing Glass Liner in Teeth; Lesion in 38 participants. Status unknown.

Timeline

1 January 2014

Primary endpoint
1 July 2016

1 January 2020

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	38
Start date	1 January 2014
Primary completion	1 July 2016
Estimated completion	1 January 2020

Drugs / interventions tested

Glass Liner

Conditions studied

Teeth; Lesion — all drugs for Teeth; Lesion →
Dental Root Caries — all drugs for Dental Root Caries →

Sponsor

Hacettepe University

Who can join

Adults 18 to 67, any sex, with Teeth; Lesion or Dental Root Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this double-blind, randomized trial is to compare the clinical performance of a composite restorations in root surface carious lesions with or without resin modified glass ionomer lining.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of cavity lining on the restoration of root surface carious lesions: a split-mouth, 5-year randomized controlled clinical trial.
Koc Vural U, Gokalp S, Kiremitci A. · · 2020 · cited 3× · PMID 31273529 · DOI 10.1007/s00784-019-03001-z

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03802539 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 14 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03802539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing